Literature DB >> 12597363

Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans.

Takashi Sugita1, Shoko Kurosaka, Maki Yajitate, Hitomi Sato, Akemi Nishikawa.   

Abstract

Strains of a human pathogenic yeast, Candida albicans, have (A) intronless, (B) intron-containing, and (C) a mixture of intron-containing and intronless 26S rRNA genes. To elucidate the significance of these three genotypes in pathogenesis, we measured two major virulence factors, extracellular proteinase and phospholipase activity, in 56 clinical isolates of C. albicans, and investigated the relationship between genotype and enzymatic activity. The genotype B strains had significantly higher proteinase and phospholipase activities than genotypes A or C. These results suggest that to understand the pathogenesis of C. albicans, the genotypes should be considered.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12597363     DOI: 10.1111/j.1348-0421.2002.tb02776.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

1.  A new model of vaginal infection by Candida albicans in rats.

Authors:  Márcia A Carrara; Lucélia Donatti; Edílson Damke; Terezinha I E Svidizinski; Márcia E L Consolaro; Márcia R Batista
Journal:  Mycopathologia       Date:  2010-06-09       Impact factor: 2.574

2.  In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity.

Authors:  Gordon Ramage; Brent Coco; Leighann Sherry; Jeremy Bagg; David F Lappin
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

3.  Inhibition of virulence factors of Candida spp. by different surfactants.

Authors:  Juliana Pereira Lyon; Fábio Vieira dos Santos; Pedro Claudio Guaranho de Moraes; Leonardo Marmo Moreira
Journal:  Mycopathologia       Date:  2010-07-31       Impact factor: 2.574

4.  A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells.

Authors:  Mary Mayumi Taguti Irie; Márcia Edilaine Lopes Consolaro; Terezinha Aparecida Guedes; Lucélia Donatti; Eliana Valéria Patussi; Terezinha Inez Estivalet Svidzinski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Genotype analyses of human commensal scalp fungi, Malassezia globosa, and Malassezia restricta on the scalps of patients with dandruff and healthy subjects.

Authors:  Midori Hiruma; Otomi Cho; Masataro Hiruma; Sanae Kurakado; Takashi Sugita; Shigaku Ikeda
Journal:  Mycopathologia       Date:  2014-05-05       Impact factor: 2.574

6.  Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.

Authors:  M E L Consolaro; T A Albertoni; A E Svidzinski; R M Peralta; T I E Svidzinski
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

7.  Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.

Authors:  Arianna Tavanti; Giacomo Pardini; Daniele Campa; Paola Davini; Antonella Lupetti; Sonia Senesi
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions.

Authors:  M E L Consolaro; A Gasparetto; T I E Svidzinski; R M Peralta
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

9.  In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.

Authors:  Edílson Damke; Joyce K Tsuzuki; Diógenes A G Cortez; Izabel C P Ferreira; Thâmara A Bertoni; Márcia R Batista; Lucélia Donati; Terezinha I E Svidzinski; Márcia E L Consolaro
Journal:  BMC Complement Altern Med       Date:  2011-05-04       Impact factor: 3.659

10.  Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis.

Authors:  Kelen Fátima Dalben Dota; Marcia Edilaine Lopes Consolaro; Terezinha Inez Estivalet Svidzinski; Marcos Luciano Bruschi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.